Isolation of Avian Influenza A(H5N1) Viruses from Humans - Hong Kong, May-December 1997

Morbidity and Mortality Weekly Report

Volumn 46, Issue 50, 1997, Pages 1204-1207

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CASE REPORT; CHILD; FEMALE; HONG KONG; HUMAN; INFLUENZA; INFLUENZA VIRUS A; INFLUENZA VIRUS A H5N1; ISOLATION AND PURIFICATION; MALE; MIDDLE AGED; PRESCHOOL CHILD; VIROLOGY;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; FEMALE; HONG KONG; HUMANS; INFLUENZA A VIRUS; INFLUENZA A VIRUS, H5N1 SUBTYPE; INFLUENZA, HUMAN; MALE; MIDDLE AGED;

EID: 0031578614     PISSN: 01492195     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (8)

1. Cox N, Patriarca P. Influenza pandemic preparedness plan for the United States. J Infect Dis 1997;176(suppl 1):S4-S7.
2. Douglas RG. Drug therapy: prophylaxis and treatment of influenza. N Engl J Med 1990;322:443-50.
3. Tominack RL, Hayden FG. Rimantadine hydrochloride and amantadine hydrochloride use in influenza A virus infections. Infect Dis Clin North Am 1987;1:459-78.
4. Hayden FG. Antivirals for pandemic influenza. J Infect Dis 1997;176(suppl 1):S56-S61.
5. Belshe RB, Burk B, Newman F, Cerruti RL, Sim IS. Resistance of influenza A virus to amantadine and rimantadine: results of one decade of surveillance. J Infect Dis 1989;159:430-5.
6. Ziegler T, Hemphill M, Zeigler ML, Klimov A, Cox N. Rimantadine resistance of influenza A viruses: an international surveillance. Presented at the 7th ISAR Conference, Charleston, South Carolina, March 1994.
7. CDC. Update: influenza activity - worldwide, March-August 1997. MMWR 1997;46:815-8.
8. CDC. Update: influenza activity - United States, 1997-98 season. MMWR 1997;46:1192-4.